Login / Signup

Alzheimer's Disease and COVID-19 Pathogenic Overlap: Implications for Drug Repurposing.

Mahdieh Golzari-SorkhehImindu LiyanageMark A ReedDonald F Weaver
Published in: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques (2023)
Keyphrases
  • coronavirus disease
  • sars cov
  • cognitive decline
  • adverse drug
  • emergency department
  • mild cognitive impairment
  • electronic health record